1-3 of 3
James Krempski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer

Available to Purchase
Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Krempski, Deborah Bahr, Joshua Daum, Kimberly R. Kalli, Ellen L. Goode, Matthew S. Block, Martin J. Cannon, Keith L. Knutson
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6667–6678.
https://doi.org/10.1158/0008-5472.CAN-17-0740
Published: 30 November 2017
View articletitled, IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Open the PDF for IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB

Available to Purchase
Lavakumar Karyampudi, Purushottam Lamichhane, James Krempski, Kimberly R. Kalli, Marshall D. Behrens, Doris M. Vargas, Lynn C. Hartmann, Jo Marie T. Janco, Haidong Dong, Karen E. Hedin, Allan B. Dietz, Ellen L. Goode, Keith L. Knutson
Journal: Cancer Research
Cancer Res (2016) 76 (2): 239–250.
https://doi.org/10.1158/0008-5472.CAN-15-0748
Published: 14 January 2016
View articletitled, PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB
Open the PDF for PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB in another window
Includes: Supplementary data
Journal Articles

Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity

Available to Purchase
Cory Allen, Sompong Vongpunsawad, Takafumi Nakamura, C. David James, Mark Schroeder, Roberto Cattaneo, Caterina Giannini, James Krempski, Kah-Whye Peng, Jenny M. Goble, Joon H. Uhm, Stephen J. Russell, Evanthia Galanis
Journal: Cancer Research
Cancer Res (2006) 66 (24): 11840–11850.
https://doi.org/10.1158/0008-5472.CAN-06-1200
Published: 18 December 2006
View articletitled, Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
Open the PDF for Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity in another window
Includes: Supplementary data